- GlycoMimetics Reports Highlights and Financial Results for Fourth Quarter and Full Year 2023
- GlycoMimetics to Report Fourth Quarter and 2023 Full Year Financial Results on March 27, 2024
- GlycoMimetics to Participate in Upcoming Cowen 44th Annual Health Care Conference
- GlycoMimetics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
- GlycoMimetics Announces Positive Initial Safety and Pharmacokinetic Results from Phase 1a Healthy Volunteer Study of GMI-1687
More ▼
Key statistics
As of last trade GlycoMimetics Inc (GLYC:NMQ) traded at 3.00, -15.01% below its 52-week high of 3.53, set on Jan 23, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.07 |
---|---|
High | 3.11 |
Low | 2.90 |
Bid | 3.00 |
Offer | 3.03 |
Previous close | 3.18 |
Average volume | 388.25k |
---|---|
Shares outstanding | 64.39m |
Free float | 62.43m |
P/E (TTM) | -- |
Market cap | 204.77m USD |
EPS (TTM) | -0.6366 USD |
Data delayed at least 15 minutes, as of Mar 28 2024 17:58 BST.
More ▼